SPONSOR

Massachusetts General Hospital

Total Trials

Recruiting

Phases

Phase 3, Phase 1, Phase 2, Phase 1, Phase 2, Phase 4

Conditions studied: Psychosis Schizophrenia Lynch Syndrome Crohn Disease Inflammatory Bowel Diseases Healthy Diabetes Mellitus, Type 2 Subarachnoid Hemorrhage, Aneurysmal Type 2 Myocardial Infarction Hypertensive Disorder of Pregnancy

Massachusetts General Hospital is a clinical research sponsor with 44 registered studies on ClinicalTrials.gov, of which 44 are actively recruiting participants. Research covers conditions including Psychosis, Schizophrenia, Lynch Syndrome, Crohn Disease.

The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Massachusetts General Hospital

How many clinical trials has Massachusetts General Hospital sponsored?

ClinicalMetric currently tracks 44 clinical trials sponsored by Massachusetts General Hospital, of which 44 are actively recruiting participants. These trials cover conditions including Psychosis, Schizophrenia, Lynch Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Massachusetts General Hospital research focus on?

Massachusetts General Hospital clinical trials span Psychosis, Schizophrenia, Lynch Syndrome, Crohn Disease, Inflammatory Bowel Diseases, and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Massachusetts General Hospital clinical trial?

To participate in a Massachusetts General Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Massachusetts General Hospital trials with current recruitment status updated daily.

Massachusetts General Hospital

Frequently Asked Questions — Massachusetts General Hospital

Clinical Trials by Massachusetts General Hospital

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes

Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage

Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia

Pilot Study of a Behavioral Program for Resident Depression in Skilled Nursing Facilities

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Promoting Well-being and Health in Heart Failure

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Atezolizumab+Bevacizumab+SBRT in Unresectable HCC

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts

Leveraging Interventions for Caregiver Growth, Health, Training, Empowerment and Navigation: Comparing Group Behavioral Interventions to Improve Dementia Caregiver Strain

Modulation Effect of tACS on Chronic Low Back Pain

Behavioral Intervention for Youth to Promote Vaping Cessation

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Cannabis, Linked Emotions, and Adolescent Risk Study

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Metabolomic Biomarkers of Myotonic Dystrophy

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

South Africa Smoking Cessation and Engagement in HIV/TB Care Care

Delayed Tolerance Through Mixed Chimerism

Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

DNA Analysis of Blood and Tissue From Patients With Lung Cancer

Well-being in IBS: Strengths and Happiness (WISH) 2.0

SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Ivosidenib as Post-HSCT Maintenance for AML

Ziftomenib Maintenance Post Allo-HCT

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

The HALT Biomarker Study

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

Buspirone for Anxiety in Autistic Youth

Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)